Colon Adenocarcinoma

• CLINICAL_TRIALS trial_result · 2026-01-22
  Clinical Trial Update: Optimization of Adaptive Text Messages for Cancer Survivors (OATS II) [NA]

  This update notes the completion of the OATS II trial evaluating adaptive text messaging for cancer survivors, with results posted on 2026-0…

• CLINICAL_TRIALS trial_result · 2025-11-20
  Clinical Trial Update: Encorafenib, Cetuximab, and Nivolumab in Treating Patients With Microsatellite Stable, BRAFV600E Mutated Unresectable or Metastatic Colorectal Cancer [Phase 1, Phase 2]

  A Phase 1/2 clinical trial is evaluating a triple combination of encorafenib, cetuximab, and nivolumab in patients with microsatellite-stabl…

• CLINICAL_TRIALS trial_result · 2025-08-12
  Clinical Trial Update: Pilot Study for Colorectal Cancer and Advanced Adenoma Detection With the Mainz Biomed Colorectal Cancer Test

  A pilot study is evaluating Mainz Biomed Colorectal Cancer Test for detecting colorectal cancer and advanced adenoma. The study is currently…

• CLINICAL_TRIALS trial_result · 2025-07-20
  Clinical Trial Update: Oxaliplatin, Leucovorin, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer [Phase 3]

  Phase 3 trial evaluating oxaliplatin, leucovorin, and fluorouracil with or without bevacizumab as adjuvant therapy after surgery for Stage I…

• CLINICAL_TRIALS trial_result · 2025-06-08
  Clinical Trial Update: MoLiMoR - A Study With FOLFIRI-based First-line Therapy With or Without Intermittent Cetuximab [Phase 2]

  A Phase 2 study (MoLiMoR) evaluated first-line FOLFIRI-based therapy with or without intermittent cetuximab in colon and rectal adenocarcino…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2025-04-27
  Clinical Trial Update: Circulating Tumor DNA Testing in Predicting Treatment for Patients With Stage IIA Colon Cancer After Surgery [Phase 2, Phase 3]

  A Phase 2/3 trial evaluates circulating tumor DNA testing to predict and guide adjuvant treatment decisions for patients with Stage IIA colo…

• CLINICAL_TRIALS trial_result · 2024-11-27
  Clinical Trial Update: M7824 in Patients With Metastatic Colorectal Cancer or With Advanced Solid Tumors With Microsatellite Instability [Phase 1, Phase 2]

  Phase 1/2 clinical trial results for bintrafusp alfa (M7824) in metastatic colorectal cancer and MSI-H advanced solid tumors have been poste…

• CLINICAL_TRIALS trial_result · 2024-05-21
  Clinical Trial Update: Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal Cancer [Phase 2]

  Phase 2 clinical trial update evaluating panitumumab, regorafenib, and TAS-102 in patients with metastatic and/or unresectable RAS wild-type…

• CLINICAL_TRIALS trial_result · 2023-08-08
  Clinical Trial Update: Savolitinib in Treating Patients With MET Amplified Metastatic or Unresectable Colorectal Cancer [Phase 2]

  Phase 2 trial investigating savolitinib for MET-amplified metastatic or unresectable colorectal cancer was terminated with results posted.

• CLINICAL_TRIALS trial_result · 2020-07-17
  Clinical Trial Update: Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II Trial [Phase 2]

  Phase II trial evaluating combined neoadjuvant systemic therapy with PIPAC for colorectal peritoneal metastasis in patients eligible for CRS…

• CLINICAL_TRIALS trial_result · 2020-07-07
  Clinical Trial Update: Nintedanib and Capecitabine in Treating Patients With Refractory Metastatic Colorectal Cancer [Phase 1, Phase 2]

  Phase 1/2 study evaluating nintedanib with capecitabine in refractory metastatic colorectal cancer has completed with posted results.

• CLINICAL_TRIALS trial_result · 2012-12-03
  Clinical Trial Update: Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer [Phase 3]

  Phase 3 trial evaluating FOLFIRI with or without bevacizumab in patients after surgery for stage II/III colon cancer; results posted in 2012…